262 related articles for article (PubMed ID: 29560733)
41. Investigation of the apoptotic pathway induced by benzimidazole-oxindole conjugates against human breast cancer cells MCF-7.
Lakshma Nayak V; Nagaseshadri B; Vishnuvardhan MVPS; Kamal A
Bioorg Med Chem Lett; 2016 Jul; 26(14):3313-3317. PubMed ID: 27262596
[TBL] [Abstract][Full Text] [Related]
42. Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents.
Luo G; Muyaba M; Lyu W; Tang Z; Zhao R; Xu Q; You Q; Xiang H
Bioorg Med Chem Lett; 2017 Feb; 27(4):867-874. PubMed ID: 28110871
[TBL] [Abstract][Full Text] [Related]
43. Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies.
Kamath PR; Sunil D; Ajees AA; Pai KS; Das S
Bioorg Chem; 2015 Dec; 63():101-9. PubMed ID: 26469742
[TBL] [Abstract][Full Text] [Related]
44. H2O-mediated isatin spiro-epoxide ring opening with NaCN: Synthesis of novel 3-tetrazolylmethyl-3-hydroxy-oxindole hybrids and their anticancer evaluation.
Sharma P; Senwar KR; Jeengar MK; Reddy TS; Naidu VG; Kamal A; Shankaraiah N
Eur J Med Chem; 2015 Nov; 104():11-24. PubMed ID: 26413726
[TBL] [Abstract][Full Text] [Related]
45. Antiproliferative effect, cell cycle arrest and apoptosis generation of novel synthesized anticancer heterocyclic derivatives based 4H-benzo[h]chromene.
Alblewi FF; Okasha RM; Hritani ZM; Mohamed HM; El-Nassag MAA; Halawa AH; Mora A; Fouda AM; Assiri MA; Al-Dies AM; Afifi TH; El-Agrody AM
Bioorg Chem; 2019 Jun; 87():560-571. PubMed ID: 30928878
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and pharmacological evaluation of novel bisindolylalkanes analogues.
Song YL; Dong YF; Yang T; Zhang CC; Su LM; Huang X; Zhang DN; Yang GL; Liu YX
Bioorg Med Chem; 2013 Dec; 21(24):7624-7. PubMed ID: 24262885
[TBL] [Abstract][Full Text] [Related]
47. Cytotoxic and antimicrobial evaluations of novel apoptotic and anti-angiogenic spiro cyclic 2-oxindole derivatives of 2-amino-tetrahydroquinolin-5-one.
Ghozlan SA; Mohamed MF; Ahmed AG; Shouman SA; Attia YM; Abdelhamid IA
Arch Pharm (Weinheim); 2015 Feb; 348(2):113-24. PubMed ID: 25664629
[TBL] [Abstract][Full Text] [Related]
48. Design, synthesis and biological activities of tetrandrine and fangchinoline derivatives as antitumer agents.
Li D; Liu H; Liu Y; Zhang Q; Liu C; Zhao S; Jiao B
Bioorg Med Chem Lett; 2017 Feb; 27(3):533-536. PubMed ID: 28057423
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and Biological Evaluation of Indole-2-carbohydrazide Derivatives as Anticancer Agents with Anti-angiogenic and Antiproliferative Activities.
Zhang J; Liu T; Chen M; Liu F; Liu X; Zhang J; Lin J; Jin Y
ChemMedChem; 2018 Jun; 13(12):1181-1192. PubMed ID: 29637713
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and biological evaluation of novel indole-pyrimidine hybrids bearing morpholine and thiomorpholine moieties.
Diao PC; Li Q; Hu MJ; Ma YF; You WW; Hong KH; Zhao PL
Eur J Med Chem; 2017 Jul; 134():110-118. PubMed ID: 28410492
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, structure-activity relationship studies and biological evaluation of novel 2,5-disubstituted indole derivatives as anticancer agents.
Hu H; Wu J; Ao M; Wang H; Zhou T; Xue Y; Qiu Y; Fang M; Wu Z
Chem Biol Drug Des; 2016 Nov; 88(5):766-778. PubMed ID: 27315790
[TBL] [Abstract][Full Text] [Related]
52. Development of 2-oindolin-3-ylidene-indole-3-carbohydrazide derivatives as novel apoptotic and anti-proliferative agents towards colorectal cancer cells.
Eldehna WM; Abo-Ashour MF; Al-Warhi T; Al-Rashood ST; Alharbi A; Ayyad RR; Al-Khayal K; Abdulla M; Abdel-Aziz HA; Ahmad R; El-Haggar R
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):319-328. PubMed ID: 33345633
[TBL] [Abstract][Full Text] [Related]
53. Indole-coumarin-thiadiazole hybrids: An appraisal of their MCF-7 cell growth inhibition, apoptotic, antimetastatic and computational Bcl-2 binding potential.
Kamath PR; Sunil D; Joseph MM; Abdul Salam AA; T T S
Eur J Med Chem; 2017 Aug; 136():442-451. PubMed ID: 28525842
[TBL] [Abstract][Full Text] [Related]
54. Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in vitro biological evaluation, and QSAR studies.
Sabt A; Abdelhafez OM; El-Haggar RS; Madkour HMF; Eldehna WM; El-Khrisy EEAM; Abdel-Rahman MA; Rashed LA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1095-1107. PubMed ID: 29944015
[TBL] [Abstract][Full Text] [Related]
55. Synthesis, crystal structures and antitumor activity of two platinum(II) complexes with methyl hydrazinecarbodithioate derivatives of indolin-2-one.
Li YS; Peng B; Ma L; Cao SL; Bai LL; Yang CR; Wan CQ; Yan HJ; Ding PP; Li ZF; Liao J; Meng YY; Wang HL; Li J; Xu X
Eur J Med Chem; 2017 Feb; 127():137-146. PubMed ID: 28039772
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and anticancer activity of some novel indolo[3,2-b]andrographolide derivatives as apoptosis-inducing agents.
Song Y; Xin Z; Wan Y; Li J; Ye B; Xue X
Eur J Med Chem; 2015 Jan; 90():695-706. PubMed ID: 25506809
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and biological evaluation of 2-indolinone derivatives as potential antitumor agents.
Zou H; Zhang L; Ouyang J; Giulianotti MA; Yu Y
Eur J Med Chem; 2011 Dec; 46(12):5970-7. PubMed ID: 22019188
[TBL] [Abstract][Full Text] [Related]
58. Design, synthesis and biological evaluation of 1,3-diphenyl-1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents.
Reddy TS; Kulhari H; Reddy VG; Bansal V; Kamal A; Shukla R
Eur J Med Chem; 2015 Aug; 101():790-805. PubMed ID: 26231080
[TBL] [Abstract][Full Text] [Related]
59. Azole-hydrazone derivatives: Design, synthesis, in vitro biological evaluation, dual EGFR/HER2 inhibitory activity, cell cycle analysis and molecular docking study as anticancer agents.
Labib MB; Philoppes JN; Lamie PF; Ahmed ER
Bioorg Chem; 2018 Feb; 76():67-80. PubMed ID: 29153588
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and biological evaluation of certain hydrazonoindolin-2-one derivatives as new potent anti-proliferative agents.
Eldehna WM; Al-Wabli RI; Almutairi MS; Keeton AB; Piazza GA; Abdel-Aziz HA; Attia MI
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):867-878. PubMed ID: 29707975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
